BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 10748947)

  • 1. Safety of second generation antihistamines.
    Philpot EE
    Allergy Asthma Proc; 2000; 21(1):15-20. PubMed ID: 10748947
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and central nervous system impairment of newer-generation prescription antihistamines in seasonal allergic rhinitis.
    Spangler DL; Brunton S
    South Med J; 2006 Jun; 99(6):593-9. PubMed ID: 16800414
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Double-blind, placebo-controlled study comparing the efficacy and safety of fexofenadine hydrochloride (120 and 180 mg once daily) and cetirizine in seasonal allergic rhinitis.
    Howarth PH; Stern MA; Roi L; Reynolds R; Bousquet J
    J Allergy Clin Immunol; 1999 Nov; 104(5):927-33. PubMed ID: 10550734
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A review of the efficacy of desloratadine, fexofenadine, and levocetirizine in the treatment of nasal congestion in patients with allergic rhinitis.
    Bachert C
    Clin Ther; 2009 May; 31(5):921-44. PubMed ID: 19539095
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of seasonal allergic rhinitis: comparative efficacy of the newer-generation prescription antihistamines.
    Conboy-Ellis K
    J Am Acad Nurse Pract; 2005 Aug; 17(8):295-301. PubMed ID: 16045589
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loratadine versus cetirizine: assessment of somnolence and motivation during the workday.
    Salmun LM; Gates D; Scharf M; Greiding L; Ramon F; Heithoff K
    Clin Ther; 2000 May; 22(5):573-82. PubMed ID: 10868555
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the potential cardiotoxicity of the antihistamines terfenadine, astemizole, loratadine, and cetirizine in atopic children.
    Delgado LF; Pferferman A; Solé D; Naspitz CK
    Ann Allergy Asthma Immunol; 1998 Apr; 80(4):333-7. PubMed ID: 9564984
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The costs of nonsedating antihistamine therapy for allergic rhinitis in managed care: an updated analysis.
    Liao E; Leahy M; Cummins G
    Am J Manag Care; 2001 Oct; 7(15 Suppl):S459-68. PubMed ID: 11680261
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Onset of action for the relief of allergic rhinitis symptoms with second-generation antihistamines.
    Greisner WA
    Allergy Asthma Proc; 2004; 25(2):81-3. PubMed ID: 15176489
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessing satisfaction with desloratadine and fexofenadine in allergy patients who report dissatisfaction with loratadine.
    Glass DJ; Harper AS
    BMC Fam Pract; 2003 Aug; 4():10. PubMed ID: 12917016
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The systemic safety of fexofenadine HCl.
    Mason J; Reynolds R; Rao N
    Clin Exp Allergy; 1999 Jul; 29 Suppl 3():163-70; discussion 171-3. PubMed ID: 10444232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetic overview of oral second-generation H1 antihistamines.
    González MA; Estes KS
    Int J Clin Pharmacol Ther; 1998 May; 36(5):292-300. PubMed ID: 9629995
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomized double-blind comparison of cetirizine and fexofenadine after pollen challenge in the Environmental Exposure Unit: duration of effect in subjects with seasonal allergic rhinitis.
    Day JH; Briscoe MP; Rafeiro E; Hewlett D; Chapman D; Kramer B
    Allergy Asthma Proc; 2004; 25(1):59-68. PubMed ID: 15055564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A descriptive analysis of the use and cost of new-generation antihistamines in the treatment of allergic rhinitis: a retrospective database analysis.
    Lee J; Cummins G; Okamoto L
    Am J Manag Care; 2001 May; 7(4 Suppl):S103-12. PubMed ID: 11392821
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical pharmacokinetics and pharmacodynamics of desloratadine, fexofenadine and levocetirizine : a comparative review.
    Devillier P; Roche N; Faisy C
    Clin Pharmacokinet; 2008; 47(4):217-30. PubMed ID: 18336052
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-interventional study comparing treatment satisfaction in patients treated with antihistamines.
    De Vos C; Mitchev K; Pinelli ME; Derde MP; Boev R
    Clin Drug Investig; 2008; 28(4):221-30. PubMed ID: 18345712
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sedation with "non-sedating" antihistamines: four prescription-event monitoring studies in general practice.
    Mann RD; Pearce GL; Dunn N; Shakir S
    BMJ; 2000 Apr; 320(7243):1184-6. PubMed ID: 10784544
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Efficacy and safety of fexofenadine and cetirizine in the treatment of allergic rhinitis].
    López García A; Paz Martínez D; Orea Solano M; Hernández Valencia G; Ramírez García A; Ramírez Ojeda H; Sánchez Medal LF; Soda Mehry A; Velarde Domínguez T; Betancourt Suárez MA; Méndez Vera JL
    Rev Alerg Mex; 2001; 48(6):168-72. PubMed ID: 11802289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A double-blind, randomized, single-dose, crossover comparison of levocetirizine with ebastine, fexofenadine, loratadine, mizolastine, and placebo: suppression of histamine-induced wheal-and-flare response during 24 hours in healthy male subjects.
    Grant JA; Riethuisen JM; Moulaert B; DeVos C
    Ann Allergy Asthma Immunol; 2002 Feb; 88(2):190-7. PubMed ID: 11868924
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of bepotastine, cetirizine, fexofenadine, and olopatadine on histamine-induced wheal-and flare-response, sedation, and psychomotor performance.
    Takahashi H; Ishida-Yamamoto A; Iizuka H
    Clin Exp Dermatol; 2004 Sep; 29(5):526-32. PubMed ID: 15347340
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.